Cargando…
Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy
Photodynamic Therapy (PDT) with methyl-aminolevulinate acid (MAL-PDT) is being used for the treatment of Basal cell carcinoma (BCC), but recurrences have been reported. In this work, we have evaluated resistance mechanisms to MAL-PDT developed by three BCC cell lines (ASZ, BSZ and CSZ), derived from...
Autores principales: | Lucena, Silvia Rocio, Zamarrón, Alicia, Carrasco, Elisa, Marigil, Miguel Angel, Mascaraque, Marta, Fernández-Guarino, Montserrat, Gilaberte, Yolanda, González, Salvador, Juarranz, Angeles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423284/ https://www.ncbi.nlm.nih.gov/pubmed/30886381 http://dx.doi.org/10.1038/s41598-019-41313-y |
Ejemplares similares
-
Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy
por: Gracia-Cazaña, Tamara, et al.
Publicado: (2019) -
Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer
por: Lucena, Silvia Rocío, et al.
Publicado: (2015) -
TGFβ1 Secreted by Cancer-Associated Fibroblasts as an Inductor of Resistance to Photodynamic Therapy in Squamous Cell Carcinoma Cells
por: Gallego-Rentero, María, et al.
Publicado: (2021) -
Metformin as an Adjuvant to Photodynamic Therapy in Resistant Basal Cell Carcinoma Cells
por: Mascaraque, Marta, et al.
Publicado: (2020) -
Mitotic Catastrophe Induced in HeLa Tumor Cells by Photodynamic Therapy with Methyl-aminolevulinate
por: Mascaraque, Marta, et al.
Publicado: (2019)